Plain-English translation of NCT07390851 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing whether adding magnesium sulfate to lidocaine—a common numbing medication used in trigger point injections—works better than lidocaine alone for treating myofascial pain dysfunction syndrome (a condition causing chronic muscle pain and tightness). Researchers will compare how well the medication relieves pain and relaxes muscles by measuring your pain levels and checking your muscle activity with special equipment.
People with chronic muscle pain often don't get complete relief from standard treatments, and doctors are looking for ways to make trigger point injections more effective. This medication combination might offer better pain relief and muscle relaxation, which could improve treatment options for patients suffering from this condition.
You likely qualify if…
You likely don't qualify if…
You will receive injections directly into the painful muscle trigger points in your neck, jaw, or upper back. Half of participants will receive standard numbing medication alone, while the other half will receive the same medication combined with magnesium sulfate. Your pain will be measured before and after the injection, and a special device will measure your muscle activity at rest and when you contract your muscles to see how well the treatment works.
AI-generated summary from trial data · Jun 3, 2026 · Not medical advice
Egypt